Documents
Application Sponsors
ANDA 212248 | FRESENIUS KABI USA | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 234MG/ML | 0 | SODIUM CHLORIDE 23.4% | SODIUM CHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-04-28 | STANDARD |
Submissions Property Types
CDER Filings
FRESENIUS KABI USA
cder:Array
(
[0] => Array
(
[ApplNo] => 212248
[companyName] => FRESENIUS KABI USA
[docInserts] => ["",""]
[products] => [{"drugName":"SODIUM CHLORIDE 23.4%","activeIngredients":"SODIUM CHLORIDE","strength":"234MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/28\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-04-28
)
)